Orlixon

Medicinal product

(Invented) name

Orlixon

Active substance (s)

Deksametazono natrio fosfatas

Strength

4 mg/ml

Pharmaceutical form

injekcinis ar infuzinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis, leisti į sąnarį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

H02AB02, Dexamethasone

Marketing authorisation holder

UAB Adeofarma, Lietuva

Date of authorisation

2021-06-14

Date of renewal

Documents

1540-001_Orlixon 4mg-ml_inj_inf_tirp_PZPL_2021-06-14.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Ampulėje (1 ml) yra	1 ml
Deksametazono natrio fosfatas	4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106697	92800	1092800	ampulė	1 ml N25	ASPĮ	Receptinis	LT/L/21/1540/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-06-14	Registruotas